Ebbe Svaneklink

Management, SVANEKLINK HOLDING 2012 ApS

Lyøvej 231 active role

Ebbe Svaneklink holds 1 active role in Danish companies registered in CVR, including Management at SVANEKLINK HOLDING 2012 ApS since 2012. Ebbe Svaneklink is registered as legal owner of SVANEKLINK HOLDING 2012 ApS (100% share band). 2 earlier roles have ended, the most recent in 2022.

Overview

Active roles

directorships & management

Past roles

historical positions

Dissolved companies

Career timeline

2017 – 2019
Board of Directors, GV A/S
2012 – now
Management, SVANEKLINK HOLDING 2012 ApS
2012 – 2022
Board of Directors, GARANT MIDTJYLLAND ApS

Personal details

Address

Lyøvej 23

Companies & roles

Active roles

1 positions

Company	Role	Period	Ownership	Status
SVANEKLINK HOLDING 2012 ApS CVR 34602905	ManagementManagement	Since 2012	100%	Active

Historical roles

2 positions

Company	Role	Period	Ownership	Status
GV A/S CVR 39176351	BoardBoard of Directors	2017 – 2019	—	Dissolved
GARANT MIDTJYLLAND ApS CVR 25475518	BoardBoard of Directors	2012 – 2022	—	Active

Network

Company network

Active roles

Ebbe Svaneklink

SVANEKLINK HOLDING 2012 ApS

Management

Past companies

GV A/S GARANT MIDTJYLLAND ApS

Co-directors & shared companies

No shared company connections found.

Is this you? About the data on this page

This profile is compiled automatically from CVR / Virk, the official business register in Denmark. Riskpilot is operated by Risika A/S, which is the data controller for this page. We don't add private information — only the roles and details the register itself publishes.

Because this is public register data, it can't be erased — corrections to the underlying record are made with the register, and we pick them up once they're published. You do have the right to object to how your details are shown here, and we can de-index this profile so it no longer appears in search engines such as Google.

To make a request, email privacy@risika.com with a link to this page. We respond within 30 days. Read more in our privacy policy.